ReviewBreast (Edinburgh, Scotland)2025
Collecting high-quality data for advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 2).
Review in Breast (Edinburgh, Scotland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The systematic collection and analysis of high-quality advanced breast cancer (ABC) data is necessary to advance understanding, optimize care, and improve patient outcomes. High-quality data enables understanding of treatment effectiveness, thereby facilitating the development of innovative therapies. ABC data may also help to counter stigma, by demonstrating that many living with the disease continue to contribute meaningfully to society. Data is an essential tool in highlighting global inequities and advocating to overcome them, and prevalence data is key to determining the burden of ABC worldwide, informing healthcare policies and investment in ABC care. This manuscript reviews global efforts to improve the collection and analysis of ABC data over the past decade. It highlights the advances and persistent challenges to high-quality data collection and proposes actions for the decade ahead. It summarizes research conducted for the ABC Global Alliance's Global Decade Report 2.0. The main findings are: a) New methodologies yield more accurate estimates of the number of people with ABC; b) Data linkage initiatives reveal ABC prevalence far higher than earlier projections; c) ABC-focused registries have advanced data collection globally over the decade; d) High-quality ABC data has been shown to drive treatment access and policy change; e) Persistent gaps in recurrence data and registries remain. The findings from the ABC Global Alliance's Global Decade Report 2.0 have informed the development of a new ABC Global Charter. The ABC Global Charter 2.0 defines ten new achievable and measurable goals for the decade 2025-2035, aiming at improving the lives of people living with ABC worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.